FFG COIN GRANT RECEIVED!
Gene therapies shouldn’t cost millions per patient. Yet manufacturing remains one of the biggest bottlenecks.
At bespark*bio we’re on the mission to change that!
Together with four exceptional partners – Novasign, Holloid, Engenes and Qubicon – we are building an adaptive, next-generation AAV manufacturing platform.










